文献速递银屑病与炎症性皮肤病

二甲双胍通过富集嗜黏蛋白阿克曼菌调节色氨酸代谢保护小鼠免受葡萄糖加重的银屑病样皮炎

Metformin Treatment Protects Mice from Glucose-Promoted Psoriasiform Dermatitis through Enrichment of Akkermansia muciniphila with Modulation of Bacterial Tryptophan Metabolites.
PubMed 文献 · J Invest Dermatol · 2025-08-27

该研究在小鼠中探讨二甲双胍抗银屑病作用与肠道菌群的关系。4周葡萄糖摄入加重银屑病样皮炎,口服二甲双胍可缓解;该效应由肠道菌群介导。二甲双胍富集的嗜黏蛋白阿克曼菌(Akkermansia muciniphila)或Amuc_1100改善葡萄糖喂养小鼠的银屑病样皮炎,并逆转血清吲哚-3-乙酸降低;吲哚-3-乙酸可保护小鼠并抑制表皮S100A8表达。

要点

  • 葡萄糖摄入4周加重小鼠银屑病样皮炎,二甲双胍口服可缓解。
  • 二甲双胍的保护作用由肠道菌群介导,与富集嗜黏蛋白阿克曼菌相关。
  • 嗜黏蛋白阿克曼菌或Amuc_1100通过提升吲哚-3-乙酸、抑制表皮S100A8改善皮炎。

核心结论

  • 二甲双胍通过富集嗜黏蛋白阿克曼菌并调节细菌色氨酸代谢物吲哚-3-乙酸,逆转葡萄糖加重的银屑病样皮炎。

研究设计与样本

  • 动物实验:小鼠接受4周葡萄糖摄入以加重银屑病样皮炎,并给予口服二甲双胍治疗。
  • 机制研究:通过补充嗜黏蛋白阿克曼菌或Amuc_1100,以及口服和皮内注射吲哚-3-乙酸,评估对皮炎的影响。

主要发现

  • 4周葡萄糖摄入加重小鼠银屑病样皮炎,口服二甲双胍可缓解。
  • 二甲双胍富集的嗜黏蛋白阿克曼菌或Amuc_1100改善葡萄糖喂养小鼠的银屑病样皮炎,但对对照小鼠无效。
  • 葡萄糖摄入降低血清吲哚-3-乙酸水平,嗜黏蛋白阿克曼菌和Amuc_1100可逆转该降低。
  • 口服或皮内注射吲哚-3-乙酸保护小鼠免受葡萄糖加重的银屑病样皮炎,并抑制表皮抗菌肽S100A8表达。

临床怎么用

  • 提示二甲双胍可能通过肠道菌群-色氨酸代谢轴改善银屑病,为代谢干预提供机制依据。
  • 嗜黏蛋白阿克曼菌、Amuc_1100或吲哚-3-乙酸可能成为银屑病辅助干预的潜在靶点。

局限性

  • 研究仅在小鼠模型中进行,结论尚未在人体验证。
  • 具体分子机制及临床转化价值仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although diet has been regarded as a potential environmental risk factor for psoriasis, the precise contribution of specific dietary components, such as sugar, to its pathogenesis remains uncertain. Metformin, a primary medication for type II diabetes mellitus, has been documented to yield improvements in psoriasis. Earlier research indicates that the antihyperglycemic impact of metformin is associated with changes in gut microbiota. Nonetheless, the role of gut microbiota in the antipsoriatic effects of metformin remains unclear. In this study, we showed that 4 weeks of glucose intake exacerbated psoriasiform dermatitis (PsD) in mice, which resolved with oral metformin treatment. The exacerbation and resolution of PsD were mediated through effects on the gut microbiota. Supplementation with Akkermansia muciniphila, enriched by metformin, or Amuc_1100 improved PsD in glucose-fed mice but not in the control mice. Glucose intake resulted in reduced serum levels of indole-3-acetic acid, a microbial tryptophan metabolite, which were reversed by A muciniphila and Amuc_1100 treatment. Oral administration and intradermal injection of indole-3-acetic acid protected mice from glucose-promoted PsD with suppressed expression of antimicrobial peptides, specifically S100A8, in the epidermis. Collectively, increases of A muciniphila through metformin treatment led to reversal of glucose-promoted PsD in mice, possibly through production of the microbial tryptophan metabolite indole-3-acetic acid.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Lai Y, Jiang Z, Qiu X, et al. Metformin Treatment Protects Mice from Glucose-Promoted Psoriasiform Dermatitis through Enrichment of Akkermansia muciniphila with Modulation of Bacterial Tryptophan Metabolites. J Invest Dermatol. 2025. PMID: 40876504. doi:10.1016/j.jid.2025.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。